Today's Updates

US Health Department Seeks Public Feedback on Vaccine Guidelines After Trump Order
Published Date: 26 Aug 2026

The U.S. health department said on Friday it was seeking public feedback on federal vaccine recommendations, including how they ⁠are categorized and communicated, after...

Read More
Less Seniors Taking Inappropriate Cognitive Meds
Published Date: 26 Aug 2026

Older adults with cognitive disorders who use inappropriate medications linked to adverse cognitive effects are more likely to have poor mental health-related quality of life.

Read More
Alzheimer's Blood Test Gets FDA Clearance
Published Date: 26 Aug 2026

The U.S. Food and Drug Administration has cleared Roche and partner Eli Lilly's blood ⁠test to help identify signs of Alzheimer's disease in people aged 55 and older with...

Read More
Cognitive Therapy Boosts Brain Function in Schizophrenia
Published Date: 26 Aug 2026

Structured cognitive remediation therapy helps boost brain activity, working memory, and quality of life and reduce severity of symptoms in patients with schizophrenia, a trial shows.

Read More
Are Microplastics Feeding Cancer Risk?
Published Date: 26 Aug 2026

Microplastics are everywhere, in the environment and the human body. But as public concern about possible health effects grows, evidence of a cancer connection remains thin.

Read More
Preschoolers With Cancer Have Poor Motor Skills
Published Date: 26 Aug 2026

Preschool children newly diagnosed with cancer exhibit significant motor impairments, reduced mobility, and weak grip strength at diagnosis, study shows.

Read More
Does Maintenance Therapy Extend Life in mCRC?
Published Date: 26 Aug 2026

Maintenance therapy is linked to longer overall survival after first-line bevacizumab-based combination chemotherapy in patients with metastatic colorectal cancer, a study finds.

Read More
Breast Cancer Survivors: Who Benefits From Weight-Loss Meds?
Published Date: 26 Aug 2026

The oral drug naltrexone-bupropion helps some breast cancer survivors lose weight.

Read More
Fixed-Duration Combo Shows Promise for Relapsed MCL
Published Date: 26 Aug 2026

Researchers examine the efficacy of fixed-duration mosunetuzumab plus polatuzumab vedotin in patients with heavily pretreated relapsed/refractory mantle cell lymphoma.

Read More
Ruxolitinib Reduces Acute GVHD in Transplant Patients
Published Date: 26 Aug 2026

A phase 3 trial evaluates a low-dose ruxolitinib-based regimen for graft-vs-host disease prophylaxis among patients undergoing haploidentical hematopoietic stem-cell transplantation.

Read More
US Cancer Trials Heavily Favor Single Drugs Over Care Issues
Published Date: 26 Aug 2026

Industry trials focus on single drugs, while publicly funded trials often look at broader cancer care. It’s a ‘complementary’ approach, but pharma enrolls over 90% of patients.

Read More

Latest News


Latest News

News All Time


Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Preoperative MRI is useful for identifying additional disease in breast cancer patients with nodes positive.

2.

Positive Trials; Malignancies Increasing in Younger Adults; Andre Braugher's Cancer Dx.

3.

No Gestational Diabetes-Cancer Link; Cholesterol and Cancer; Oncologist Saves Umpire

4.

Research finds COVID-19 mRNA vaccine sparks immune response to fight cancer

5.

FDA Approves Iberdomide Combo for Multiple Myeloma



© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot